Intercept Pharma Europe Ltd. BRISTOL


Intercept Pharma Europe started in year 2014 as Private Limited Company with registration number 09224395. The Intercept Pharma Europe company has been functioning successfully for 10 years now and its status is active. The firm's office is based in Bristol at One. Postal code: BS2 0ZX. Since 2014-10-13 Intercept Pharma Europe Ltd. is no longer carrying the name Intercept Pharma Uk.

The company has 3 directors, namely Kathleen M., Graham H. and Rocco V.. Of them, Rocco V. has been with the company the longest, being appointed on 17 March 2021 and Kathleen M. and Graham H. have been with the company for the least time - from 24 January 2023. At the moment there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.

Intercept Pharma Europe Ltd. Address / Contact

Office Address One
Office Address2 Glass Wharf
Town Bristol
Post code BS2 0ZX
Country of origin United Kingdom

Company Information / Profile

Registration Number 09224395
Date of Incorporation Thu, 18th Sep 2014
Industry Wholesale of pharmaceutical goods
End of financial Year 31st December
Company age 10 years old
Account next due date Sun, 31st Dec 2023 (122 days after)
Account last made up date Fri, 31st Dec 2021
Next confirmation statement due date Mon, 14th Oct 2024 (2024-10-14)
Last confirmation statement dated Sat, 30th Sep 2023

Company staff

Kathleen M.

Position: Director

Appointed: 24 January 2023

Graham H.

Position: Director

Appointed: 24 January 2023

Rocco V.

Position: Director

Appointed: 17 March 2021

Quayseco Limited

Position: Corporate Secretary

Appointed: 19 August 2015

David F.

Position: Director

Appointed: 24 January 2023

Resigned: 21 November 2023

Stephanie K.

Position: Director

Appointed: 24 January 2023

Resigned: 23 November 2023

Olufemi A.

Position: Director

Appointed: 19 October 2021

Resigned: 01 July 2022

Willem V.

Position: Director

Appointed: 28 June 2021

Resigned: 01 July 2022

Michael G.

Position: Director

Appointed: 28 June 2021

Resigned: 24 January 2023

Linda R.

Position: Director

Appointed: 28 June 2021

Resigned: 24 January 2023

Caroline S.

Position: Director

Appointed: 09 December 2020

Resigned: 29 October 2021

Stephen A.

Position: Director

Appointed: 30 September 2020

Resigned: 26 February 2021

Robert C.

Position: Director

Appointed: 30 September 2020

Resigned: 07 January 2021

Daniel H.

Position: Director

Appointed: 05 September 2019

Resigned: 03 July 2020

Sandip K.

Position: Director

Appointed: 28 September 2016

Resigned: 26 March 2021

Lisa B.

Position: Director

Appointed: 28 September 2016

Resigned: 30 September 2020

Daniel H.

Position: Secretary

Appointed: 28 September 2016

Resigned: 03 July 2020

Mark P.

Position: Director

Appointed: 19 August 2015

Resigned: 01 January 2021

Bryan Y.

Position: Director

Appointed: 18 September 2014

Resigned: 04 December 2017

Barbara D.

Position: Director

Appointed: 18 September 2014

Resigned: 28 September 2016

Bryan Y.

Position: Secretary

Appointed: 18 September 2014

Resigned: 04 December 2017

People with significant control

The list of persons with significant control that own or have control over the company includes 1 name. As we identified, there is Intercept Pharmaceuticals, Inc. from Morristown, United States. This PSC is classified as "a corporate", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.

Intercept Pharmaceuticals, Inc.

305 Madison Avenue, 37th Floor, Morristown, New Jersey, 07960, United States

Legal authority Delaware C-Corporation
Legal form Corporate
Country registered Delaware
Place registered Usa
Registration number 3565213
Notified on 6 April 2016
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company previous names

Intercept Pharma Uk October 13, 2014

Company filings

Filing category
Accounts Address Annual return Capital Change of name Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
Full accounts data made up to 2022-12-31
filed on: 17th, February 2024
Free Download (46 pages)

Company search

Advertisements